4-(2,4,6-Trimethyl-3-cyclohexen-1-yl)-3-buten-2-one
Common Name: |
4-(2,4,6-Trimethyl-3-cyclohexen-1-yl)-3-buten-2-one |
IUPAC Name: |
(E)-4-(2,4,6-trimethylcyclohex-3-en-1-yl)but-3-en-2-one |
Molecular Formula: |
C13H20O |
SMILES: |
CC1CC(=CC(C1C=CC(=O)C)C)C |
Inchi: |
1S/C13H20O/c1-9-7-10(2)13(11(3)8-9)6-5-12(4)14/h5-7,10-11,13H,8H2,1-4H3/b6-5+ |
Inchi Key: |
FETSKTIMHFKZNF-AATRIKPKSA-N |
Cas No: |
67801-38-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
192.30 |
Mass (g/mol) |
192.151 |
Molar Refractivity |
61.74 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
276.00 to 277.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.62 |
LogP |
3.37 |
iLOGP |
2.87 |
XLOGP3 |
2.65 |
WLOGP |
3.37 |
MLOGP |
2.94 |
ESOL Log S |
-2.57 |
ESOL Solubility (mg/ml) |
0.518 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.66 |
Ali Solubility (mg/ml) |
0.42 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.20 |
Silicos-IT Solubility (mg/ml) |
1.22 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.59 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.624 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.684 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |